Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanosine monophosphate reductase pseudogene is a nonfunctional DNA sequence in the human genome homologous to the functional guanosine monophosphate reductase gene (GMPR or GMPR2). Pseudogenes like this arise from gene duplication or retrotransposition events; they typically contain mutations that prevent generation of a functional protein. While they resemble true genes in sequence, they are not transcribed and translated into functional proteins, and have no established role as therapeutic targets, biomarkers, or drug receptors[2]. The canonical therapeutic enzyme is "Guanosine monophosphate reductase" (GMPR or GMPR2), which participates in nucleotide metabolism and is a functional enzyme[1][3][4][6][7]. This entry refers exclusively to a pseudogene, not the active gene or its protein product. The Ensembl identifier ENSG00000224692, when checked against current genomic databases, specifically labels this entry as a pseudogene. If structured information is required for a druggable target, one should refer to the functional gene (e.g., GMPR or GMPR2), not the pseudogene[4][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanosine monophosphate reductase pseudogene.